Écrit par GBI Research | 25 Avril 2012

NEW YORK (GBI Research), 25 April 2012 - Drug prices in Russia are stabilising, but disparity still exists in the pharmaceutical market, according to a new report by business intelligence experts GBI Research.

The new report* states that the new 2010 law “on the circulation of drugs” has helped by setting a price barrier for a selection of medications, but there is still some way to...

Écrit par Afssaps | 25 Avril 2012

Utilisation du baclofène dans le traitement de l’alcoolo-dépendance : actualisation


De nouvelles données relatives à l’utilisation et à la sécurité d’emploi du baclofène (Lioresal et générique) dans le traitement de l’alcoolo-dépendance conduisent l’Agence française de sécurité sanitaire des produits de santé (Afssaps) à actualiser son point d’information de...

Écrit par WHO | 25 Avril 2012

24 April 2012 | Geneva – On the eve of World Malaria Day 2012, the World Health Organization (WHO) hails global progress in combating malaria but highlights the need to further reinforce the fight.  WHO’s new initiative, T3: Test. Treat. Track, urges malaria-endemic countries and donors to move towards universal access to diagnostic testing and antimalarial treatment, and to build...

Écrit par GBI Research | 24 Avril 2012

NEW YORK (GBI Research), 24 April 2012 - Generic drugs are evolving and, at the same time, being outshone by their predecessors – super-powered pharmaceuticals developed through simplified development pathways – according to a new report by healthcare intelligence company GBI Research.

The new report* indicates that the development of “supergenerics” is creating significant...